GORDON CARL L Insider Trading Activity

Average Profitability
15.05%
Insider Buys Quantity
18
Insider Buys Sum
$120.97M
Insider Sells Quantity
40
Insider Sells Sum
$245.98M

Insider Activity of GORDON CARL L

Biography of GORDON CARL L

No biography is available at this moment.

2025-04-09SaleCompass Therapeutics, Inc.
CMPX
3.57M
2.6156%
$1.59$5.68M+113.71%
2024-08-13SaleKeros Therapeutics, Inc.
KROS
director
250,000
0.6566%
$44.01$11M-67.67%
2024-01-30PurchaseArriVent BioPharma, Inc. Common Stock
AVBP
222,222
0.5025%
$18.00$4M0%
2024-01-25PurchaseAdicet Bio, Inc.
ACET
3.13M
7.0488%
$2.40$7.5M-41.7%
2023-06-27PurchaseAdicet Bio, Inc.
ACET
875,000
1.9987%
$2.09$1.83M-16.9%
2022-11-08PurchaseCompass Therapeutics, Inc.
CMPX
director
402,000
0.2887%
$3.21$1.29M-25.18%
2022-05-11PurchaseCompass Therapeutics, Inc.
CMPX
30,722
0.0412%
$2.49$76,498+69.57%
2022-05-06PurchaseCompass Therapeutics, Inc.
CMPX
24,447
0.0229%
$1.60$39,115+83.73%
2021-11-04PurchaseCompass Therapeutics, Inc.
CMPX
5.36M
10.3195%
$3.50$18.75M-22%
2021-03-30SaleORIC Pharmaceuticals, Inc.
ORIC
director
55,738
0.1536%
$23.93$1.33M-27.12%
2021-03-29SaleORIC Pharmaceuticals, Inc.
ORIC
director
151,110
0.404%
$23.31$3.52M-27.35%
2021-03-26SaleORIC Pharmaceuticals, Inc.
ORIC
director
55,632
0.1525%
$23.88$1.33M-27.01%
2021-03-25SaleORIC Pharmaceuticals, Inc.
ORIC
director
103,046
0.2846%
$24.70$2.55M-28.75%
2021-03-24SaleORIC Pharmaceuticals, Inc.
ORIC
director
65,918
0.1848%
$24.80$1.63M-27.78%
2021-03-23SaleORIC Pharmaceuticals, Inc.
ORIC
director
7,984
0.011%
$12.16$97,085-27.16%
2021-03-22SaleORIC Pharmaceuticals, Inc.
ORIC
director
15,346
0.0215%
$13.23$203,104-31.47%
2021-03-19SaleORIC Pharmaceuticals, Inc.
ORIC
director
42,550
0.058%
$13.23$563,149-33.08%
2021-03-18SaleORIC Pharmaceuticals, Inc.
ORIC
director
12,118
0.0345%
$28.03$339,668-34.02%
2021-03-17SaleORIC Pharmaceuticals, Inc.
ORIC
director
37,580
0.1011%
$28.43$1.07M-38.46%
2021-03-16SaleORIC Pharmaceuticals, Inc.
ORIC
director
82,706
0.2217%
$27.72$2.29M-36.89%
Total: 54
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.